Canada markets open in 3 hours 3 minutes

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.77000.0000 (0.00%)
At close: 04:00PM EDT
1.7800 +0.01 (+0.56%)
After hours: 07:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 639.84M
Enterprise Value 390.51M
Trailing P/E 3.74
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)180.24
Price/Book (mrq)2.22
Enterprise Value/Revenue 169.05
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 3-42.16%
S&P500 52-Week Change 328.04%
52 Week High 33.7300
52 Week Low 30.9200
50-Day Moving Average 31.9868
200-Day Moving Average 31.6665

Share Statistics

Avg Vol (3 month) 33.79M
Avg Vol (10 day) 31.88M
Shares Outstanding 5361.49M
Implied Shares Outstanding 6361.49M
Float 8124.06M
% Held by Insiders 11.15%
% Held by Institutions 165.88%
Shares Short (Apr 30, 2024) 423.44M
Short Ratio (Apr 30, 2024) 48.63
Short % of Float (Apr 30, 2024) 449.10%
Short % of Shares Outstanding (Apr 30, 2024) 49.52%
Shares Short (prior month Mar 28, 2024) 421.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3May 21, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,011.77%

Management Effectiveness

Return on Assets (ttm)-40.08%
Return on Equity (ttm)-102.72%

Income Statement

Revenue (ttm)2.31M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)4,608.30%
Gross Profit (ttm)N/A
EBITDA -185.36M
Net Income Avi to Common (ttm)-193.58M
Diluted EPS (ttm)-0.8300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)355.6M
Total Cash Per Share (mrq)1.44
Total Debt (mrq)106.24M
Total Debt/Equity (mrq)36.78%
Current Ratio (mrq)15.58
Book Value Per Share (mrq)1.17

Cash Flow Statement

Operating Cash Flow (ttm)-185.41M
Levered Free Cash Flow (ttm)-111.15M